REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/17/2026
Back to search
Official data from USPTO
CLINX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
08/17/2026
Trademark type
Combined
Nice classes
35, 36, 42
Filing date
10/30/2018
Registration date
08/17/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2021
Last transaction
08/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/01/2017
First use in commerce
11/01/2017
Drawing code
5
Owner type
16
Owner location
Quincy, MA, US
Examiner
SOBRAL, CHRISTINA
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letters "Clin" in bold black letters next to a stylized oversized blue "X".
Holders and representatives
Holders
Clin-X, LLC
Representatives
John E. Ottaviani Partridge Snow & Hahn LLP
Technical classification
Nice Classes
Class 35Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsproviding business information management services; Providing operational business development assistance to clinical research sites of others; conducting business feasibility studies; providing regulatory submission management assistance with clinical research in the nature of assisting research clinics in the study start-up process for clinical research biopharmaceutical and biotechnology companies; providing business development to a network of investigation sites and providing independent review of clinical trials for business purposes through a network of investigational sites; Patient recruitmentretentionmarketing servicesoperation of telephone call centerdesign of advertising and marketing materials for othersdeveloping and support of plans for patient outreach in the nature of posting of clinical trial notices for the purpose of recruiting patients for participating in clinical trials for the testing of drugsmanagement of traditional and online advertising campaigns to recruit patientsbusiness management services for clinical studies conducted by others
Class 36
Financial consulting services for clinical studies conducted by others
Class 42
Consulting services for others in the field of clinical trial planning
Publications
History of USPTO decisions and trademark events.
47 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/17/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/15/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/11/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/11/2021
IUAF
USE AMENDMENT FILED
06/30/2021
EISU
TEAS STATEMENT OF USE RECEIVED
06/30/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/11/2021
EX2G
SOU EXTENSION 2 GRANTED
03/09/2021
EXT2
SOU EXTENSION 2 FILED
03/09/2021
EEXT
SOU TEAS EXTENSION RECEIVED
03/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/12/2020
EX1G
SOU EXTENSION 1 GRANTED
09/10/2020
EXT1
SOU EXTENSION 1 FILED
09/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/10/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2020
PUBO
PUBLISHED FOR OPPOSITION
01/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/09/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/09/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/09/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/06/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/23/2019
GNFR
FINAL REFUSAL E-MAILED
08/23/2019
CNFR
FINAL REFUSAL WRITTEN
08/23/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2019
ALIE
ASSIGNED TO LIE
08/15/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2019
GNRT
NON-FINAL ACTION E-MAILED
02/06/2019
CNRT
NON-FINAL ACTION WRITTEN
02/06/2019
DOCK
ASSIGNED TO EXAMINER
02/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/14/2018
NWAP
NEW APPLICATION ENTERED
11/02/2018
Continuous trademark protection
Get notified about every new filing that threatens CLINX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.